# HCPCS J0491: Inj Belantamab Mafodotin-blmf 1 Mg

Medicare HCPCS J0491 has a Medicare Part B payment limit of $18.46 per 1 MG under 2026 Q4 Medicare Part B drug (ASP) pricing, the same in every state.

Web page: https://www.med-reveal.com/rates/J0491-hcpcs-fee-schedule
Section: Drugs and Biologicals
Billed by: Rheumatology

## Medicare rates

| | Amount |
| --- | --- |
| National non-facility | $18.46 |
| National facility | $18.46 |
| Release | 2026 Q4 (effective 2026-10-01) |

## Related codes

- J0571: Buprenorphine oral 1mg — https://www.med-reveal.com/rates/J0571-hcpcs-fee-schedule
- J0572: Bupren/nal up to 3mg bupreno — https://www.med-reveal.com/rates/J0572-hcpcs-fee-schedule
- J0573: Bupren/nal 3.1 to 6mg bupren — https://www.med-reveal.com/rates/J0573-hcpcs-fee-schedule
- J0574: Bupren/nal 6.1 to 10mg bupre — https://www.med-reveal.com/rates/J0574-hcpcs-fee-schedule
- J0575: Bupren/nal over 10mg bupreno — https://www.med-reveal.com/rates/J0575-hcpcs-fee-schedule
- J1010: Inj Betamethasone Acet+sod Phos 3 Mg — https://www.med-reveal.com/rates/J1010-hcpcs-fee-schedule
- J1230: Methadone injection — https://www.med-reveal.com/rates/J1230-hcpcs-fee-schedule
- J3357: Inj Ustekinumab 1 Mg — https://www.med-reveal.com/rates/J3357-hcpcs-fee-schedule

Commercial negotiated rates for J0491 by payer and state: https://www.med-reveal.com/solutions/rate-benchmarking

## Sources

- CMS Medicare fee schedules (2026 Q4): https://www.cms.gov/medicare/payment/fee-schedules